The treatment of solid tumors faces substantial hurdles because of inadequate drug delivery and the immunosuppressive tumor microenvironment. To address these challenges, we developed a therapeutic platform using macrophages loaded with ferritin-drug conjugates, referred to as macrophage-drug conjugates (MDC), and applied it to glioblastoma, an immunologically cold solid tumor. MDC loaded with ferritin-conjugated monomethyl auristatin E enabled efficient, cell contact-dependent transfer of the payload by a mechanism involving transfer of iron-binding proteins, from either mouse or human macrophages preferentially into glioma cells. This targeted delivery and therapeutic efficacy was demonstrated across in vitro coculture systems, ex vivo assays using dissociated glioblastoma patient tumor samples, and in vivo using orthotopic glioblastoma mouse models, all while maintaining a favorable preclinical safety profile evidenced by minimal systemic toxicity and localized drug biodistribution. Beyond direct tumor cell killing leading to significant tumor regression and prolonged survival in these models, MDC therapy reprogrammed the immunosuppressive tumor microenvironment. Immune profiling by spectral flow cytometry revealed enhanced infiltration and activation of cytotoxic T lymphocytes and B lymphocytes while reducing immunosuppressive regulatory T cells. This culminated in a robust, durable, T cell-dependent antitumor immune response, the necessity of which was confirmed through studies in immunodeficient mouse models and by lymphocyte depletion, and which conferred protection against tumor rechallenge. The combined cytotoxic and immunomodulatory effects highlight the potential of MDC therapy as a promising strategy for glioblastoma treatment and support its further clinical development.
Aim of the study:Data concerning the clinical manifestation and outcomes of lean metabolic dysfunction-associated steatotic liver disease (MASLD) are scarce and inconsistent. The aim of the study was to evaluate the clinical characteristics of MASLD and predictors of its occurrence. Material and methods:The study included patients from the Polish Gallstone Surgery Registry diagnosed with MASLD according to the current criteria. Results:Among 3,419 patients, MASLD was diagnosed in 24.2%. Lean MASLD was diagnosed in 11.3% of patients with MASLD. Independent predictors of lean MASLD were atherogenic dyslipidaemia (OR = 94.16, CI: 45.54-197.71, p < 0.0001), diabetes mellitus or prediabetes conditions (OR = 9.26, CI: 4.42-19.38, p < 0.0001) and hypertension (OR = 2.97, CI: 1.38-6.41, p = 0.0054). Conclusions:Lean MASLD is not a rare form of the disease, and in the lean MASLD group there are patients with a high rate of metabolic abnormalities which may significantly increase cardiovascular risk and the risk of MASLD progression.
This study evaluated how various types of guar meal in diets of broiler chickens affect their rearing results, carcass composition, and liver histology. The experiment was conducted in one hundred sixty Ross 308 broilers randomly allocated to four groups consisting of the same number of birds (C, GM1, GM2, and GM3). The birds were reared for over 42 days and fed with starter (days 1–21), grower (days 22–35), and finisher (days 36–42) rations. All feed rations were prepared using maize meal, soybean meal, oil, mineral, and feed additives. The experimental factor was guar meal type included in feed rations (starter, grower, and finisher stage) at 6% each: C (control group)—without guar meal, GM1—raw guar meal, GM2—Microlam, and GM3—roasted guar meal. Microlam is a high-protein animal feed produced by laminating and micronizing guar meal for enhanced digestibility and protein content, while roasted guar meal (also called korma) is a more basic protein supplement for livestock and poultry that has undergone roasting to improve its taste and digestibility. It was shown that 6% of raw guar meal in the feed rations affected significantly higher (2646 g) body weight of broilers in comparison to birds fed the same amount of Microlam (2583 g), however feed conversion ratio were similar (1.63–1.65 kg/kg; p > 0.05) in all groups. Thus similar musculature and fatness, broiler chickens from GM1 and GM2 groups obtained higher dressing percentage in compare to group GM3 (p ≤ 0.05). No significant effect of guar meal on the physical characteristics (except pH1), or the results of the proximate composition of the breast muscles was found. Rations fed to broiler chickens had no effect on the microscopic image of the liver or reaction to the presence of neutral fats. In summary, 6% inclusion of raw guar meal should be recommended in broiler chicken diets as a partial substitute for soybean meal because it contributes to achieving the best growth performance results as well as dressing percentage, without deterioration carcass composition, and liver histology.
NATO jako podmiot transepokowy w historii ewolucji globalnej architektury bezpieczeństwa, został poddany w erze postzimnowojennej naturalnej presji dostosowawczo-transformacyjnej w zakresie misji funkcjonowania i wykorzystywania potencjału. Pod wpływem dyskursu wewnątrzsojuszniczego, ale także m.in. presji zewnętrznej, jak również w związku z potrzebami systemu międzynarodowego, dokonywał przewartościowań strategicznych. Miały one różne skutki – tak dla systemu, jak i zapisów podstawy funkcjonowania NATO. Historia jednak po raz kolejny upomina się o powrót do strategicznych źródeł – tj. odzyskanie właściwych priorytetów i witalności. Tytułowa rola Polski prezentowana jest w niniejszym artykule jako rola państwa o szczególnym wpływie na „odzyskiwanie” NATO, jak również o wyjątkowej roli w NATO „odzyskanym”.